23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination

      , ,
      Trends in Parasitology
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Plasmodium vivax is the major species of malaria parasite outside Africa. It is especially problematic in that the infection can relapse in the absence of mosquitoes by activation of dormant hypnozoites in the liver. Medicines that target the erythrocytic stages of Plasmodium falciparum are also active against P. vivax, except where these have been compromised by resistance. However, the only clinical therapy against relapse of vivax malaria is the 8-aminoquinoline, primaquine. This molecule has the drawback of causing haemolysis in genetically sensitive patients and requires 14 days of treatment. New, safer and more-easily administered drugs are urgently needed, and this is a crucial gap in the broader malaria-elimination agenda. New developments in cell biology are starting to open ways to the next generation of drugs against hypnozoites. This search is urgent, given the time needed to develop a new medication. Copyright 2010 Elsevier Ltd. All rights reserved.

          Related collections

          Author and article information

          Journal
          Trends in Parasitology
          Trends in Parasitology
          Elsevier BV
          14714922
          March 2010
          March 2010
          : 26
          : 3
          : 145-151
          Article
          10.1016/j.pt.2009.12.005
          20133198
          ed8257e3-3400-4798-95f5-e533bfe9cb36
          © 2010

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article